CN Patent

CN109414417A — 通过paris的法尼基化预防或治疗帕金森症的方法

Assigned to Sungkyunkwan University School Industry Cooperation · Expires 2019-03-01 · 7y expired

What this patent protects

揭示预防或治疗受试者的帕金森症的方法，其中，将有效量的药物给药至受试者，以造成PARIS的法尼基化以及脑内PGC‑1α表达的提升。这些方法部分地通过预防多巴胺神经元的丢失而减轻受试者帕金森症的效应。

USPTO Abstract

揭示预防或治疗受试者的帕金森症的方法，其中，将有效量的药物给药至受试者，以造成PARIS的法尼基化以及脑内PGC‑1α表达的提升。这些方法部分地通过预防多巴胺神经元的丢失而减轻受试者帕金森症的效应。

Drugs covered by this patent

Patent Metadata

Patent number
CN109414417A
Jurisdiction
CN
Classification
—
Expires
2019-03-01
Drug substance claim
No
Drug product claim
No
Assignee
Sungkyunkwan University School Industry Cooperation
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.